Solventum Corporation

SOLVNYSEHealthcare● Active

$81.01

$-1.41(-1.71%)

Market Cap$14.0B

P/E Ratio—

52W High$88.2

52W Low$62.38

Avg Volume1.7M

Open$83.01

Beta0.75

PE Ratio Market Cap Forecast

Solventum Corporation (SOLV) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

solv · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Solventum Corporation (SOLV) measures how much investors pay for each dollar of the company's trailing earnings. SOLV's current PE ratio of 9.85x is calculated by dividing its stock price of $81.01 by its TTM earnings per share of $8.22. −21.5% discount vs 5Y avg 12.6x

9.85x

P/E Ratio (TTM)−21.5%

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E

11.48x

FY2027 est. EPS $7.06

Based on 10 analysts

EPS (TTM)

$8.22

TTM · diluted EPS

PEG Ratio

0.04

Below 1.0 · Growth adjusted

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Solventum Corporation SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2020 – 2025 · Annual

PE Ratio (TTM)

5Y Avg 12.6x

EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

Historical PE Range

Past 6 fiscal years · Front-end computed

Average

12.5x

6-yr mean

Median

10.3x

6-yr midpoint

Minimum

8.9x

Lowest year

Maximum

23.9x

Highest year

9.9x ← Now

8.9x
MinQ1 · 25%10.3x
MedianQ3 · 75%23.9x
Max

Within Historical Range

At 9.85x, SOLV's current P/E is within its average historical range over the past 6 fiscal years.

33th percentileHigher than 2 of 6 historical fiscal year readings

Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.

PE Ratio vs Peers

Medical - Care Facilities · 6 peers · Annual PE

Company	Market Cap	PE (Annual)	vs Avg	EPS (TTM)
Solventum CorporationYou SOLV	$14.0B	9.85x	-69.2%	$8.22
Align Technology, Inc. ALGN	$12.0B	27.60x	-13.7%	$5.66
Doximity, Inc. DOCS	$3.9B	22.23x	-30.5%	$1.05
Encompass Health Corporation EHC	$10.3B	18.84x	-41.1%	$5.63
Elanco Animal Health Incorporated ELAN	$11.8B	N/A	—	-$0.47
The Ensign Group, Inc. ENSG	$10.0B	29.02x	-9.3%	$6.00
ICON Public Limited Company ICLR	$11.4B	62.31x	+94.7%	$2.92
Industry Average 5 peers with valid PE	—	32.00x	baseline	—

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 6 of 6 years

Fiscal Year End	PE Ratio	EPS (TTM)	YoY Change
2025-12-31Latest FY2025	8.87x	$8.94	-62.9%
2024-12-31 FY2024	23.89x	$2.77	+132.7%
2023-12-31 FY2023	10.27x	$7.79	-0.1%
2022-12-31 FY2022	10.27x	$7.79	+8.7%
2021-12-31 FY2021	9.45x	$8.47	-22.1%
2020-12-31 FY2020	12.12x	$6.60	—

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

PE Ratio = Stock Price ÷ EPS (TTM)

= $81.01 ÷ $8.22 = 9.85x

TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures

Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year

PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium

Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Price history Financial statements Earnings

Frequently asked questions

SOLV pe ratio · 6 questions

SOLV's current PE ratio is 9.85x as of 2026-06-08, based on a stock price of $81.01 and TTM EPS of $8.22. Data sourced from Financial Modeling Prep via SOLV's SEC 10-K and 10-Q filings.

SOLV PE ratioWhat is SOLV PE ratioCurrent PE ratio of SOLVSOLV PE ratio today

▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Solventum Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08